109 related articles for article (PubMed ID: 15953447)
1. Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.
Scott G; Yiu SC; Wasilewski D; Song J; Smith RE
Am J Ophthalmol; 2005 Jun; 139(6):1109-10. PubMed ID: 15953447
[TBL] [Abstract][Full Text] [Related]
2. Esterified estrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women.
Khurana RN; LaBree LD; Scott G; Smith RE; Yiu SC
Am J Ophthalmol; 2006 Sep; 142(3):494-5. PubMed ID: 16935599
[TBL] [Abstract][Full Text] [Related]
3. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
[TBL] [Abstract][Full Text] [Related]
4. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.
Hickok LR; Toomey C; Speroff L
Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265
[TBL] [Abstract][Full Text] [Related]
5. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
[TBL] [Abstract][Full Text] [Related]
6. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms.
Adamson DL; Webb CM; Collins P
Menopause; 2001; 8(4):233-8. PubMed ID: 11449079
[TBL] [Abstract][Full Text] [Related]
7. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.
Kabat GC; Kamensky V; Heo M; Bea JW; Hou L; Lane DS; Liu S; Qi L; Simon MS; Wactawski-Wende J; Rohan TE
Maturitas; 2014 Sep; 79(1):70-6. PubMed ID: 25011395
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
[TBL] [Abstract][Full Text] [Related]
9. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
Penteado SR; Fonseca AM; Bagnoli VR; Abdo CH; Júnior JM; Baracat EC
Climacteric; 2008 Feb; 11(1):17-25. PubMed ID: 18202961
[TBL] [Abstract][Full Text] [Related]
10. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
Phillips TJ; Symons J; Menon S;
J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
[TBL] [Abstract][Full Text] [Related]
11. The effect of estrogen plus progestin treatment on sleep: a randomized, placebo-controlled, double-blind trial in premenopausal and late postmenopausal women.
Kalleinen N; Polo O; Himanen SL; Joutsen A; Polo-Kantola P
Climacteric; 2008 Jun; 11(3):233-43. PubMed ID: 18568788
[TBL] [Abstract][Full Text] [Related]
12. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Kujawa A; Rózycki R
Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
[TBL] [Abstract][Full Text] [Related]
13. [The "dry eye" phenomenon and ovarian function. Study of 700 women pre- and postmenopausal].
Wenderlein M; Mattes S
Zentralbl Gynakol; 1996; 118(12):643-9. PubMed ID: 9082699
[TBL] [Abstract][Full Text] [Related]
14. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
Wilson SE; Perry HD
Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
[TBL] [Abstract][Full Text] [Related]
15. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
16. Occult thyroid eye disease in patients presenting with dry eye symptoms.
Gupta A; Sadeghi PB; Akpek EK
Am J Ophthalmol; 2009 May; 147(5):919-23. PubMed ID: 19211095
[TBL] [Abstract][Full Text] [Related]
17. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
Gast MJ; Freedman MA; Vieweg AJ; De Melo NR; Girão MJ; Zinaman MJ;
Menopause; 2009; 16(2):247-56. PubMed ID: 19034054
[TBL] [Abstract][Full Text] [Related]
19. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
Simon JA; Reape KZ; Wininger S; Hait H
Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
